RDHL RedHill Biopharma Ltd. Stock Quote

RDHL [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | Israel

Index	-	P/E	-	EPS (ttm)	-2.10	Insider Own	12.96%	Shs Outstand	52.52M	Perf Week	10.89%
Market Cap	42.40M	Forward P/E	-	EPS next Y	-0.39	Insider Trans	0.00%	Shs Float	34.99M	Perf Month	-20.55%
Income	-97.70M	PEG	-	EPS next Q	-0.21	Inst Own	13.00%	Short Float	4.38%	Perf Quarter	-68.97%
Sales	85.80M	P/S	0.49	EPS this Y	-0.50%	Inst Trans	-1.76%	Short Ratio	0.77	Perf Half Y	-63.36%
Book/sh	-0.10	P/B	-	EPS next Y	46.50%	ROA	-	Target Price	12.25	Perf Year	-87.86%
Cash/sh	0.58	P/C	1.47	EPS next 5Y	-	ROE	-	52W Range	0.62 - 11.18	Perf YTD	-67.05%
Dividend	-	P/FCF	-	EPS past 5Y	1.70%	ROI	-83.90%	52W High	-92.40%	Beta	2.01
Dividend %	-	Quick Ratio	-	Sales past 5Y	285.30%	Gross Margin	52.80%	52W Low	37.11%	ATR	0.12
Employees	201	Current Ratio	-	Sales Q/Q	-11.70%	Oper. Margin	-	RSI (14)	44.36	Volatility	21.53% 14.31%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-	Profit Margin	-	Rel Volume	1.20	Prev Close	0.88
Shortable	Yes	LT Debt/Eq	-	Earnings	Jun 23 BMO	Payout	-	Avg Volume	1.99M	Price	0.85
Recom	1.70	SMA20	-3.28%	SMA50	-29.40%	SMA200	-69.44%	Volume	2,381,685	Change	-3.63%

Aug-31-21

Initiated

Cantor Fitzgerald

Overweight

$22

May-18-21

Initiated

H.C. Wainwright

Buy

$23

Sep-11-20

Initiated

BTIG Research

Buy

Jul-12-19

Upgrade

WBB Securities

Buy → Strong Buy

Mar-12-19

Upgrade

WBB Securities

Speculative Buy → Buy

Jan-26-18

Initiated

Nomura

Buy

$18

Oct-06-17

Initiated

Seaport Global Securities

Buy

$19

Oct-04-17

Reiterated

H.C. Wainwright

Buy

$33 → $36

Feb-24-17

Reiterated

FBR & Co.

Outperform

$36 → $25

Jul-27-16

Reiterated

FBR Capital

Outperform

$33 → $36

Sep-29-15

Initiated

Nomura

Buy

Jul-29-15

Reiterated

ROTH Capital

Buy

$30 → $31

Jun-17-15

Reiterated

H.C. Wainwright

Buy

$23 → $32

Jun-15-15

Reiterated

ROTH Capital

Buy

$27.50 → $30

Jun-24-22 05:31AM	Raleigh drugmaker slashes workforce as biotech downturn deepens American City Business Journals +6.72%
Jun-23-22 01:01PM	RedHill Biopharma Shares Trading Higher On Improved Q1 Profitability Benzinga
07:00AM	RedHill Biopharma Announces Q1/22 Highlights: On Track for Positive Cash from Operations in H2/22 PR Newswire
Jun-17-22 08:30AM	RedHill Biopharma to Host First Quarter 2022 Financial Results and Operational Highlights Webcast on June 23, 2022 PR Newswire
May-25-22 09:15AM	RedHill Presents New Talicia® Data Analyses at DDW 2022 PR Newswire
May-10-22 07:37AM	Raleigh drugmaker pursuing Covid treatment raising $15M to fund acquisitions American City Business Journals
May-09-22 08:30AM	RedHill Biopharma Announces $15 Million Registered Direct Offering with a Leading Healthcare Investor PR Newswire -27.03%
May-06-22 11:20AM	Cathie Woods Latest Portfolio: 10 New Stock Picks in 2022 Insider Monkey -6.33%
May-04-22 03:17PM	RedHill Biopharma Ltd. (NASDAQ:RDHL): Is Breakeven Near? Simply Wall St.
Apr-14-22 09:55AM	Redhill Biopharma Ltd. (RDHL) Could Find Support Soon, Here's Why You Should Buy the Stock Now Zacks
Apr-11-22 09:00AM	RedHill Reports Potent Inhibition of Omicron with Oral COVID-19 Drug Candidate Opaganib In Vitro PR Newswire -11.11%
08:02AM	RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib ACCESSWIRE
Mar-17-22 07:59AM	RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results PR Newswire +24.59%
Mar-15-22 09:00AM	RedHill and Kukbo Enter Oral Opaganib License for COVID-19 in South Korea PR Newswire
Mar-10-22 07:00AM	RedHill Biopharma to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights Webcast on March 17, 2022 PR Newswire
Mar-03-22 04:10AM	Shareholders in RedHill Biopharma (NASDAQ:RDHL) are in the red if they invested five years ago Simply Wall St. -7.46%
Mar-02-22 04:18PM	COVID SCIENCE-Redhill antiviral shows promise in safety study; J&J shot less effective preventing hospitalization Reuters
Mar-01-22 12:00PM	RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients Benzinga -10.05%
09:00AM	RedHill Announces Positive Phase 2 Study Results with Oral RHB-107 in Non-Hospitalized COVID-19 PR Newswire
Feb-17-22 09:30AM	RedHill Biopharma Announces Record Quarterly Revenues and First Commercial Operations Breakeven PR Newswire
Feb-07-22 01:38PM	CLARET ASSET MANAGEMENT Corp Buys Bristol-Myers Squibb Co, Shopify Inc, Hertz Global Holdings ... GuruFocus.com -5.53%
10:15AM	RedHill Biopharma's Oral Opaganib Reduces Mortality by 70% Given on Top of Remdesivir and Corticosteroids in Severe COVID-19 PR Newswire
Jan-18-22 01:38PM	Henry James International Management Inc. ... GuruFocus.com
Jan-13-22 11:51AM	RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance Benzinga
10:35AM	RedHill Biopharma's Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study in Severely Ill Hospitalized COVID-19 Patients PR Newswire
Jan-06-22 09:15AM	RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia® for the United Arab Emirates PR Newswire
Dec-20-21 08:35AM	Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing PR Newswire
08:35AM	Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing CNW Group
Dec-15-21 09:16AM	RedHill Announces Additional Insider Buying ACCESSWIRE
09:15AM	RedHill Biopharma Announces Additional Insider Buying PR Newswire
Dec-14-21 08:35AM	Virtual Conference for Life Sciences Companies Broadcast Live December 16th CNW Group -5.94%
Dec-09-21 01:05PM	RedHill Biopharma's Talicia Recommended For H. Pylori Infection Benzinga
12:19PM	Life Sciences Virtual Investor Conference: Company Executives Present Live December 16th PR Newswire
07:33AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday InvestorPlace
07:15AM	RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori ACCESSWIRE
07:00AM	RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication PR Newswire
Dec-08-21 10:58AM	Raleigh drugmaker presses forward with potential Covid treatment American City Business Journals +7.77%
Dec-06-21 07:01AM	RedHill Biopharma Ltd - Opaganib MoA Not Impacted by Omicron Mutations ACCESSWIRE
07:00AM	RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations PR Newswire
07:00AM	RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations CNW Group
Dec-03-21 04:41AM	RedHill Biopharma Ltd. (NASDAQ:RDHL) Just Reported Earnings, And Analysts Cut Their Target Price Simply Wall St. -6.93%
Dec-02-21 07:01AM	RedHill Biopharma Ltd Announces Talicia: Consistent Efficacy Irrespective of BMI ACCESSWIRE
07:00AM	RedHill Biopharma Data Published in GastroHep Shows Consistent Efficacy of Talicia Irrespective of Patient BMI PR Newswire
Dec-01-21 07:22AM	RedHill Biopharma's Movantik® Added as Preferred and Unrestricted Brand To Major National Medicare Formulary Serving Millions of Americans PR Newswire -6.85%
07:02AM	RedHills Movantik Added To Medicare Formulary ACCESSWIRE
Nov-30-21 09:30AM	RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results PR Newswire
07:02AM	RedHill Reports 3Q/2021 Financial Results ACCESSWIRE
07:00AM	RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results PR Newswire
07:00AM	RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results CNW Group
Nov-24-21 07:00AM	RedHill Biopharma to Host Third Quarter 2021 Financial Results and Operational Highlights Webcast on November 30, 2021 PR Newswire
Nov-23-21 11:10AM	RedHill Biopharma Announces Closing of $15.5 Million Public Offering of American Depositary Shares PR Newswire
Nov-19-21 02:47PM	Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble Benzinga -27.06%
12:07PM	Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge Benzinga
09:00AM	RedHill Biopharma Announces Pricing of $15.5 Million Public Offering of American Depositary Shares PR Newswire
Nov-18-21 04:01PM	RedHill Biopharma Announces Underwritten Public Offering of American Depositary Shares PR Newswire
Nov-16-21 12:12PM	When Can We Expect A Profit From RedHill Biopharma Ltd. (NASDAQ:RDHL)? Simply Wall St. -5.51%
Nov-15-21 07:02AM	RedHill Biopharma Ltd Announces RedHill: LPI in Part A of RHB-107 P2/3 COVID Study ACCESSWIRE -7.35%
07:00AM	RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients PR Newswire
Nov-09-21 07:00AM	RedHill Biopharma to Present at H.C. Wainwright 7th Annual Israel Conference and German Equity Forum (EKF) 2021 PR Newswire
Nov-08-21 07:15AM	RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill ACCESSWIRE
07:00AM	RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill PR Newswire
07:00AM	RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill CNW Group
Nov-01-21 03:21PM	11 Best Covid Vaccine and Pill Stocks To Invest In Insider Monkey
Oct-25-21 07:02AM	RedHill Biopharma Presents New Talicia(R) and Movantik(R) Data Analyses at ACG 2021 ACCESSWIRE
07:00AM	RedHill Biopharma Presents New Talicia® and Movantik® Data Analyses at ACG 2021 PR Newswire
Oct-22-21 05:51AM	Why BioNTech and RedHill Are Soaring This Week, While Novavax Is Sinking Motley Fool
Oct-20-21 07:00AM	RedHill Biopharma to Present at the BIO-Europe 2021 Conference PR Newswire +5.81%
Oct-19-21 08:33AM	David v Goliath in The Race to Develop an Oral Therapy for COVID-19 Benzinga +13.14%
Oct-18-21 07:02AM	RedHill Biopharma Announces Insider Buying ACCESSWIRE
07:00AM	RedHill Biopharma Announces Insider Buying PR Newswire
Oct-12-21 07:02AM	RedHill Biopharma Ltd Announces New U.S. Patent for RedHill's Talicia for H.pylori ACCESSWIRE
07:00AM	RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034 PR Newswire
Oct-06-21 07:02AM	RedHill Biopharma Ltd Announces Talicia(R) added to Medi-Cal CDL ACCESSWIRE
07:00AM	RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements PR Newswire
Oct-05-21 07:07AM	16 Stocks Moving in Tuesday's Pre-Market Session Benzinga
Oct-04-21 05:46PM	Why RedHill Biopharma Blasted 12% Higher Today Motley Fool +11.67%
10:33AM	RedHill Stock Higher After Covid Treatment Progresses in Trial TheStreet.com
08:48AM	RedHill's stock is up 7.0% as it shares new data about experimental COVID-19 drug MarketWatch
08:15AM	RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients ACCESSWIRE
08:00AM	RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients PR Newswire
Sep-23-21 07:00AM	RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with Aurobindo PR Newswire
Sep-15-21 11:40AM	RedHill (RDHL) Down on Unsatisfactory Data From COVID-19 Study Zacks
Sep-14-21 12:02PM	Why RedHill Biopharma Stock Is Getting Crushed Today Motley Fool -32.66%
08:15AM	RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3 Study in Severe COVID-19 Patients PR Newswire
Sep-13-21 09:10AM	RedHill Biopharma To Test Its Oral Antiviral In COVID-19 Patients In South Africa Benzinga -8.66%
07:02AM	RHB-107 P2/3 COVID-19 Study South Africa Approval ACCESSWIRE
07:00AM	RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval PR Newswire
Sep-08-21 10:29AM	RedHill's (RDHL) Opaganib Effective Against Kidney Fibrosis Zacks -7.64%
Sep-07-21 07:56AM	RedHill Unveils New Movantik Data For Opioid-Induced Constipation Benzinga
07:02AM	RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis ACCESSWIRE
06:02AM	RedHill Biopharma Ltd Announces New Movantik Analyses at PAINWeek ACCESSWIRE
06:00AM	RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021 PR Newswire
Sep-02-21 10:35AM	RedHill to Present at HCW & Cantor Conferences ACCESSWIRE
10:00AM	RedHill Biopharma to Present at H.C. Wainwright Annual Global Investment and Cantor Global Healthcare Conferences PR Newswire
Sep-01-21 10:44AM	Biotech Stock Roundup: REGN Gives Study Update, INCY Wins Drug Approval & More Zacks
Aug-31-21 04:11PM	Why RedHill Biopharma Stock Jumped on Tuesday Motley Fool +17.58%
Aug-26-21 08:44AM	RedHill Biopharma's Oral COVID-19 Candidate Shows Preclinical Action Against Delta Variant Benzinga
07:56AM	RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights PR Newswire
07:50AM	RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant PR Newswire
07:30AM	RedHill Reports Second Quarter 2021 Results ACCESSWIRE

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; and RHB-106, an encapsulated formulation for bowel preparation, which is preparing for Phase 2/3 study. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience